Nutrition and Exercise Program for Cancer Survivors
(OnPoint Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with your doctor.
What data supports the effectiveness of the treatment OnPoint for cancer survivors?
Is the Nutrition and Exercise Program for Cancer Survivors safe for humans?
How is the OnPoint treatment different from other treatments for cancer survivors?
The OnPoint treatment is unique because it combines personalized nutrition and exercise programs specifically designed for cancer survivors, focusing on improving energy balance and reducing the chronic effects of cancer. Unlike standard treatments, it emphasizes individualized interventions to enhance prognosis and survivorship outcomes through tailored diet and physical activity plans.12345
What is the purpose of this trial?
The purpose of this study is to see if survivors of breast, prostate, or colorectal cancer who receive a personal referral to a targeted nutrition and exercise program will be able to eat a healthier diet and be more physically activity.
Research Team
Tracy E Crane, PhD, RDN
Principal Investigator
University of Miami
Eligibility Criteria
This trial is for survivors of breast, prostate, or colorectal cancer. Participants should be interested in improving their diet and physical activity with the help of professionals like dietitians and exercise physiologists.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a targeted nutrition and exercise program based on their assigned complexity group
Follow-up
Participants are monitored for dietary and physical activity changes after the intervention
Treatment Details
Interventions
- Precise Oncology Interventions in Nutrition and Training (OnPoint)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor
The Applebaum Foundation
Collaborator